دورية أكاديمية
أعرض في EDS

Violacein and its antifungal activity: comments and potentialities.

التفاصيل البيبلوغرافية
العنوان: Violacein and its antifungal activity: comments and potentialities.
المؤلفون: Durán N; Laboratory of Urogenital Carcinogenesis and Immunotherapy, Department of Structural and Functional Biology, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil.; Nanomedicine Research Unit (Nanomed), Center for Natural and Human Sciences (CCNH), Universidade Federal do ABC (UFABC), Santo André, SP, Brazil., Castro GR; Nanomedicine Research Unit (Nanomed), Center for Natural and Human Sciences (CCNH), Universidade Federal do ABC (UFABC), Santo André, SP, Brazil.; Max Planck Laboratory for Structural Biology, Chemistry and Molecular Biophysics of Rosario (MPLbioR, UNR-MPIbpC). Partner Laboratory of the Max Planck Institute for Biophysical Chemistry (MPIbpC, MPG), Centro de Estudios Interdisciplinarios (CEI), Universidad Nacional de Rosario, Rosario, Santa Fe, Argentina., Portela RWD; Laboratory of Immunology and Molecular Biology, Health Sciences Institute, Universidade Federal da Bahia, Salvador, BA, Brazil., Fávaro WJ; Laboratory of Urogenital Carcinogenesis and Immunotherapy, Department of Structural and Functional Biology, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil., Durán M; Laboratory of Urogenital Carcinogenesis and Immunotherapy, Department of Structural and Functional Biology, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil., Tasic L; Biogical Chemistry Laboratory, Institute of Chemistry, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil., Nakazato G; Laboratory of Basic and Applied Bacteriology, Department of Microbiology, Biology Sciences Center, Universidade Estadual de Londrina (UEL), Londrina, Puerto Rico, Brazil.
المصدر: Letters in applied microbiology [Lett Appl Microbiol] 2022 Oct; Vol. 75 (4), pp. 796-803. Date of Electronic Publication: 2022 Jun 22.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 8510094 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1472-765X (Electronic) Linking ISSN: 02668254 NLM ISO Abbreviation: Lett Appl Microbiol Subsets: MEDLINE
أسماء مطبوعة: Publication: 2023- : Oxford : Oxford University Press
Original Publication: Oxford, UK : Published for the Society for Applied Bacteriology by Blackwell Scientific Publications, [c1985-
مواضيع طبية MeSH: Anti-Infective Agents* , Antifungal Agents*/pharmacology, Chromobacterium ; Fungi ; Humans ; Indoles
مستخلص: Violacein is an important natural antimicrobial pigment that is mainly produced by Chromobacterium violaceum and Janthinobacterium lividum. It presents a significant range of effects against phytopathogenic and human fungi, besides being featured as having low toxicity, and by its important ecological role in protecting amphibian species and applications in dyed medical fabric. The hypothesis about violacein's action mechanisms against mucormycosis (Rhizopus arrhizus) and candidiasis (Candida auris) is herein discussed based on data available in the scientific literature.
(© 2022 Society for Applied Microbiology.)
References: Araújo, F.F., Henning, A.A. and Hungria, M. (2005) Phytohormones and antibiotics produced by Bacillus subtilis and their efects on seed pathogenic fungi and on soybean root development. World J Microbiol Biotech 21, 1639-1645.
Arif, S., Batool, A., Khalid, N., Ahmed, I. and Janjua, H.A. (2017) Comparative analysis of stability and biological activities of violacein and starch capped silver nanoparticles. RSC Adv 7, 4468-4478.
Aruldass, C.A., Masalamany, S.R.L., Venil, C.K. and Ahmad, W.A. (2018) Antibacterial mode of action of violacein from Chromobacterium violaceum UTM5 against Staphylococcus aureus and methicillin resistant Staphylococcus aureus (MRSA). Environ Sci Pollut Res 25, 5164-5180.
Baidya, S., Sharma, S., Mishra, S.K., Kattel, H.P., Parajuli, K. and Sherchand, J.B. (2021) Biofilm formation by pathogens causing ventilator-associated pneumonia at intensive care units in a tertiary care hospital: an armor for refuge. Biomed Res Int 2021, 8817700.
Balestri, L.J.I., D'Agostino, I., Rango, E., Vagaggini, C., Marchitiello, R., Mariotti, M., Casian, A., Deodato, D. et al. (2022) Focused library of phenyl-fused macrocyclic amidinoureas as antifungal agents. Mol Divers 10, 1-11.
Barreto, E.S., Torres, A.R., Barreto, M.R., Vasconcelos, A.T.R., Astolfi-filho, S. and Hungria, M. (2008) Diversity in antifungal activity of strains of Chromobacterium violaceum from the Brazilian Amazon. J Ind Microbiol Biotechnol 35, 783-790.
Bhattacharya, S., Sae-Tia, S. and Fries, B.C. (2020) Candidiasis and mechanisms of antifungal resistance. Antibiotics 9, 312.
Bromberg, N., Dreyfuss, J.L., Regatieri, C.V., Palladino, M.V., Durán, N., Nader, H.B., Haun, M. and Justo, G.Z. (2010) Growth inhibition and pro-apoptotic activity of violacein in Ehrlich ascites tumor. Chem Biol Interact 186, 43-52.
Brucker, R.M., Baylor, C.M., Walters, R.L., Lauer, A., Harris, R.N. and Minbiole, K.P.C. (2008a) The identifcation of 2,4-diacetylphloroglucinol as an antifungal metabolite produced by cutaneous bacteria of the salamander Plethodon cinereus. J Chem Ecol 34, 39-43.
Brucker, R.M., Harris, R.N., Schwantes, C.R., Gallaher, T.N., Flaherty, D.C., Lam, B.A. and Minbiole, K.P.C. (2008b) Amphibian chemical defense: antifungal metabolites of the micro-symbiont Janthinobacterium lividum on the salamander Plethodon cinereus. J Chem Ecol 4, 1422-1429.
de Carvalho, D.D., Costa, F.T., Durán, N. and Haun, M. (2006) Cytotoxic activity of violacein in human colon cancer cells. Toxicol In Vitro 20, 1514-1521.
Cauz, A.C.G., Carretero, G.P.B., Saraiva, G.K.V., Park, P., Mortara, L., Cuccovia, I.M., Brocchi, M. and Gueiros-Filho, F.J. (2019) Violacein targets the cytoplasmic membrane of bacteria. ACS Infect Dis 5, 539-549.
Choi, S.Y., Lim, S., Cho, G., Kwon, J., Mun, W., Im, H. and Mitchell, R.J. (2020) Chromobacterium violaceum delivers violacein, a hydrophobic antibiotic, to other microbes in membrane vesicles. Environ Microbiol 20, 705-713.
Choi, S.Y., Lim, S., Yoon, K.H., Lee, J.I. and Mitchell, R.J. (2021) Biotechnological activities and applications of bacterial pigments violacein and prodigiosin. J Biol Eng 15, 10.
Couto, G.K., Pacheco, B.S., Borba, V.M., Junior, J.C.R., Oliveira, T.L., Segatto, N.V., Seixas, F.K., Acunha, T.V. et al. (2020) Tetra-cationic platinum (II) porphyrins like a candidate photosensitizers lodto bind, selective and drug delivery for metastatic melanoma. J Photochem Photobiol B 202, 111725.
Deda, D.K., Iglesias, B.A., Alves, E., Araki, K. and Garcia, C.R.S. (2020) Porphyrin derivative Nanoformulations for therapy and antiparasitic agents. Molecules 29, 2080.
Delattin, N., Cammue, B.P.A. and Thevissen, K. (2014) Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms. Future Med Chem 6, 77-90.
Dike-Ndudim, J.N., Ugenyi, L.C. and Ndubueze, C.W. (2021) Assessment of antifungal potentials of violacein extract from Chromobacterium violaceum isolated from domestic and recreational water sources in Owerri, Imo state. Nigeria World J Adv Res Rev 10, 168-172.
Dodou, H.V., Batista, A.H.M., Medeiros, S.C., Sales, G.W.P., Rodrigues, M.L., Pereira, P.I.O., Nogueira, P.C.N., Silveira, E.R. et al. (2020) Violacein antimicrobial activity on Staphylococcus epidermidis biofilm. Nat Prod Res 34, 3414-3417.
Durán, M., Ponezi, A.N., Faljoni-Alario, A., Teixeira, M.F.S., Justo, G.Z. and Durán, N. (2012) Potential applications of violacein: a microbial pigment. Med Chem Res 21, 1524-1532.
Durán, N., Fávaro, W.J., Brocchi, M., Justo, G.Z., Castro, G.R., Durán, M. and Nakazato, G. (2021a) Patents on violacein: a compound with great diversity of biological activities and industrial potential. Recent Patent Biotechnol 15, 102-111.
Durán, N., Justo, G.Z., Durán, M., Brocchi, M., Cordi, L., Tasic, L., Castro, G.R. and Nakazato, G. (2016) Advances in Chromobacterium violaceum and properties of violacein, its main secondary metabolite: a review. Biotechnol Adv 34, 1030-1045.
Durán, N., Justo, G.Z., Ferreira, C.V., Melo, P.S., Cordi, L. and Martins, D. (2007) Violacein: properties and biological activities. Biotechnol Appl Biochem 48, 127-133.
Durán, N., Justo, G.Z., Nakazato, G. and Fávaro, W.J. (2021c) Violacein, a microbial antiviral product: does play key role as active agent against SARS-CoV-2. AIJR Preprints, 315, Version 1. https://doi.org/10.21467/preprints.315.
Durán, N., Nakazato, G., Durán, M., Berti, I.R., Castro, G.R., Stanisic, D., Brocchi, M., Fávaro, W.J. et al. (2021b) Multi-target drug with potential applications: violacein in the spotlight. World J Microbiol Biotechnol 37, 151.
Fonseca, M.S., Rodrigues, D.M., Sokolonski, A.R., Stanisic, D., Tomé, L.M., Góes-Neto, A., Azevedo, V., Meyer, R. et al. (2022) Activity of Fusarium oxysporum-based silver nanoparticles on Candida spp. oral isolates. Nanomaterials (Basel) 12, 501.
Ghannoum, M.A. and Rice, L.B. (1999) Antifungal agent: mode of action, mechanism of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 24, 501-517.
Harris, R.N., Brucker, R.M., Walke, J.B., Becker, M.H., Schwantes, C.R., Flaherty, D.C., Lam, B.A., Woodhams, D.C. et al. (2009) Skin microbes on frogs prevent morbidity and mortality caused by a lethal skin fungus. ISME J 3, 818-824.
Haun M, Pereira MF, Riveros R, Durán N, Hoffman ME. (1988) Cytoxicity and genotoxicity of violacein and derivatives. Proc. Annual. VI. Biorganic Workshop (Brazil Chile), Santiago, January (Chile).
Houšť, J., Spížek, J. and Havlíček, V. (2020) Antifungal drugs metabolites. 10, 106.
Howard, K.C., Dennis, E.K., Watt, D.S. and Garneau-Tsodikova, S. (2020) A comprehensive overview of the medicinal chemistry of antifungal drugs: perspectives and promise. Chem Soc Rev 49, 2426-2480.
Jiang, X., Feng, K. and Yang, X. (2015) In vitro antifungal activity and mechanism of action of tea polyphenols and tea saponin against Rhizopus stolonifera. J Mol Microbiol Biotechnol 25, 269-276.
Justo, G.Z. and Durán, N. (2017) Action and function of Chromobacterium violaceum in health and disease: Violacein as a promising metabolite to counteract gastroenterological disease. Best Pract Res Clin Gastroenterol 31, 649-656.
Kanelli, M., Mandic, M., Kalakona, M., Vasilakos, S., Kekos, D., Nikodinovic-Runic, J. and Topakas, E. (2018) Microbial production of violacein and process optimization for dyeing polyamide fabrics with acquired antimicrobial properties. Front Microbiol 9, 1495.
Kang J-G, Kang H-S, Kin S-Y, Baek S-H, Baek J-H, Ahn J-M, Lee J-S, Jang I-H. (2007) Insecticide and fungicide containing violacein, and their preparation method. 2007; KR20070088150 (A).
Lee, J.-H., Kim, U.Y.-G., Gupta, V.K., Manoharan, R.K. and Lee, J. (2018) Resistant Candida albicans biofilm formation and filamentation by methylindole derivatives. Front Microbiol 9, 2641.
Lu, L., Lu, J., Wang, Y., Pang, X.-Y., Xu, M., Zhang, S.-W. and Lu, J.-O.P. (2017) Analysis of the mechanism of violacein inhibiting colon cancer cell HT29 based on differential proteomics. Sci Agric Sin 50, 1694-1704.
Martínez-Herrera, E., Frías-De-León, M.G., Hernández-Castro, R., García-Salazar, E., Arenas, R., Ocharan-Hernández, E. and Rodríguez-Cerdeira, C. (2021) Antifungal resistance in clinical isolates of Candida glabrata in Ibero-America. J Fungi (Basel) 8, 14.
Nakazato, G., Fávaro, W.J., Castro, G.R. and Durán, N. (2021a) The use of Candida auris therapies based on nanotechnology as potential novel strategy against COVID-19 infection: a mini review. AIJR Preprints, 337, Version 1. https://doi.org/10.21467/preprints.337.
Nakazato, G., Fávaro, W.J. and Durán, N. (2021b) What do we know about and what could be the strategy adopted to treat mucormycosis on post-covid-19 cases? Is it an adjuvant nanomaterial? AIJR Preprints, 330, Version 1. https://doi.org/10.21467/preprints.330.
Nakazato, G., Gonçalves, M.C., Neves, M.S., Kobayashi, R.K.T., Brocchi, M. and Durán, N. (2019) Violacein@biogenic ag system: synergistic antibacterial activity against Staphylococcus aureus. Biotechnol Lett 41, 1433-1437.
Paik S.H, Kang H-S, Jang I-H, Lee J-S, Kim S-Y, Baek J-H, Kang J-G, Ahn J-M. (2006) The antiparasitic and antifungal agent containing violacein and the method of it. Korean Patent; KR20060018386; KR100802494B.
Pereira MF. (1991) Studies on Cyto and Genotoci Action of Violacein and Derivatives in Mammal Cellular Cultures. Master Thesis, Institute of Biology, University of Campinas (Supervisor: Profa. Marcela Haun), Campinas, SP, Brazil.
Pinto, S.C., Acunha, T.V., Santurio, J.M., Denardi, L.B. and Iglesias, B.A. (2021) Investigation of powerful fungicidal activity of tetra-cationic platinum (II) and palladium (II) porphyrins by antimicrobial photodynamic therapy assays. Photodiagnosis Photodyn Ther 36, 102550.
Ries, A.S., Cargnelutti, J.F., Basso, G., Acunha, T.V., Iglesias, B.A., Flores, E.F. and Weiblen, R. (2020) Water-soluble tetra-cationic porphyrins display virucidal activity against bovine adenovirus and bovine alphaherpesvirus 1. Photodiagnosis Photodyn Ther 31, 101947.
Rivero-Berti, I., Rodenak-Kladniew, B., Onaindia, C., Adam, C.G., Islan, G.A., Durán, N. and Castro, G.R. (2020) Assessment of in vitro cytotoxicity of imidazole ionic liquids and inclusion in targeted drug carriers containing violacein. RSC Adv 10, 29336-29346.
Rossi, G.G., Guterres, K.B., Moreira, K.S., Burgo, T.A.L., de Campos, M.M.A. and Iglesias, B.A. (2021) Photo-damage promoted by tetra-cationic palladium (II) porphyrins in rapidly growing mycobacteria. Photodiagnosis Photodyn Ther 36, 102514.
Santos, L.M., Stanisic, D., Menezes, U.J., Mendonça, M.A., Barral, T.D., Seyffert, N., Azevedo, V., Durán, N. et al. (2019) Biogenic silver nanoparticles as a post-surgical treatment for Corynebacterium pseudotuberculosis infection in small ruminants. Front Microbiol 10, 824.
Sasidharan, A., Sasidharan, N.K., Amma, D.B.N.S., Vasu, R.K., Nataraja, A.V. and Bhaskaran, K. (2015) Antifungal activity of violacein purifed from a novel strain of Chromobacterium sp. NIIST (MTCC 5522). J Microbiol 53, 694-701.
Scheele, B.C., Pasmans, F., Skerratt, L.F., Berger, L., Martel, A., Beukema, W., Acevedo, A.A., Burrowes, P.A. et al. (2019) Amphibian fungal panzootic causes catastrophic and ongoing loss of biodiversity. Science 363, 1459-1463.
Senthilganesh, J., Kuppusamy, S., Durairajan, R., Subramaniyan, S.B., Veerappan, A. and Paramasivam, N. (2022) Phytolectin nanoconjugates in combination with standard antifungals curb multi-species biofilms and virulence of vulvovaginal candidiasis (VVC) causing Candida albicans and non-albicans Candida. Med Mycol 60, myab083.
Shen, J.J., Jemec, G.B.E., Arendrup, M.C. and Saunte, D.M.L. (2020) Photodynamic therapy treatment of superficial fungal infections: a systematic review. Photodiagnosis Photodyn Ther 31, 101774.
Shirata, A., Tsukamoto, T., Yasui, H., Hata, T., Hayasaka, S., Kojima, A. and Kato, H. (2000) Isolation of bacteria pro-ducing bluish-purple pigment and use for dyeing. Japan Agricult Res 34, 131-140.
Shirata, A., Tsukamoto, T., Yasui, H., Kato, H., Hayasaka, S. and Kojima, A. (1997) Production of bluish-purple pigments by Janthinobacterium lividum isolated from the raw silk and dyeing with them. Nippon Sanshigaku Zasshi 66, 377-385.
Soares Lopes, L.Q., Ramos, A.P., Copetti, P.M., Acunha, T.V., Iglesias, B.A., Vianna Santos, R.C., Machado, A.K. and Sagrillo, M.R. (2019) Antimicrobial activity and safety applications of meso-tetra(4-pyridyl) platinum (II) porphyrin. Microb Pathog 128, 47-54.
Thome, R., Issayama, L.K., DiGangi, R., Bombeiro, A.L., da Costa, T.A., Ferreira, I.T., de Oliveira, A.L.R., Machado, D.R.S. et al. (2014) Dendritic cells treated with chloroquine modulate experimental autoimmune encephalomyelitis. Immunol Cell Biol 92, 124-132.
Tortorano, A.M., Prigitano, A., Morroni, G., Brescini, L. and Barchiesi, F. (2021) Candidemia: evolution of drug resistance and novel therapeutic approaches. Infect Drug Resist 14, 5543-5553.
Verinaud, L., Lopes, S.C.P., Prado, I.C.N., Zanucoli, F., da Costa, T.A., Di Gangi, R., Issayama, L.K., Carvalho, A.C. et al. (2015) Violacein treatment modulates acute and chronic inflammation through the suppression of cytokine production and induction of regulatory T cells. PLoS ONE 10, e0125409.
Verma, S. and Pandey, A.K. (2017) An in-silico approach to explore the possible multifunctional neuroprotective efficacy of violacein against ischemic stroke. J Pharmacol 3, 17.
Vizzotto, B.S., Dias, R.S., Iglesias, B.A., Krause, L.F., Viana, A.R. and Schuch, A.P. (2020) DNA photocleavage and melanoma cells cytotoxicity induced by a meso-tetra-ruthenated porphyrin under visible light irradiation. J Photochem Photobiol B 209, 111922.
Wang, H., Wang, F., Zhu, X., Yan, Y., Yu, X., Jiang, P. and Xing, X.-H. (2012) Biosynthesis and characterization of violacein, deoxyviolacein and oxyviolacein in heterologous host, and their antimicrobial activities. Biochem Eng J 67, 148-155.
Woodhams, D.C., LaBumbard, B.C., Barnhart, K.L., Becker, M.H., Bletz, M.C., Escobar, L.A., Flechas, S.V., Forman, M.E. et al. (2018) Prodigiosin, violacein, and volatile organic compounds produced by widespread cutaneous bacteria of amphibians can inhibit two Batrachochytrium fungal pathogens. Microb Ecol 75, 1049-1062.
فهرسة مساهمة: Keywords: Chromobacterium violaceum; Janthinobacterium lividum; antifungal drug; antimicrobial pigment; fungal resistance; violacein
المشرفين على المادة: 0 (Anti-Infective Agents)
0 (Antifungal Agents)
0 (Indoles)
QJH0DSQ3SG (violacein)
تواريخ الأحداث: Date Created: 20220610 Date Completed: 20220923 Latest Revision: 20220923
رمز التحديث: 20221213
DOI: 10.1111/lam.13760
PMID: 35687081
قاعدة البيانات: MEDLINE
الوصف
تدمد:1472-765X
DOI:10.1111/lam.13760